CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Results of operations · New debt or obligation · Regulation FD disclosure · Other events
- DEF 14A Proxy Proxy Statement
- ARS Other Annual Report to Security Holders
- PRE 14A Proxy Proxy Statement (Preliminary)
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
- 4 Planned sale See Remarks sold 6,110 shares at $8.47 ($51,752)
- 4 Open-market sale See Remarks sold 64,211 shares at $8.47 ($543,797)
- 4 Open-market sale See Remarks sold 14,906 shares at $8.47 ($126,237)
- 8-K Event Regulation FD disclosure
- S-3 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 1,850,000 shares at $8.40 ($15,540,000)
- SC 13G Stake Amended Statement of Ownership
Page 11 of 28 · 558 filings